BR100 Increased By (0.45%)
BR30 Increased By (0.39%)
KSE100 Increased By (0.22%)
KSE30 Increased By (0.1%)
BECO 5.90 Decreased By ▼ -0.13 (-2.16%)
BML 57.80 Increased By ▲ 5.05 (9.57%)
BOP 34.00 Decreased By ▼ -0.25 (-0.73%)
CNERGY 8.20 Increased By ▲ 0.04 (0.49%)
DCL 12.09 Decreased By ▼ -0.25 (-2.03%)
FCCL 53.96 Increased By ▲ 0.07 (0.13%)
FCSC 5.26 Increased By ▲ 0.04 (0.77%)
FFL 18.00 Decreased By ▼ -0.03 (-0.17%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.45 Increased By ▲ 0.45 (4.09%)
KEL 8.17 Increased By ▲ 0.06 (0.74%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 88.62 Increased By ▲ 0.57 (0.65%)
NBP 186.70 Increased By ▲ 0.22 (0.12%)
PACE 11.07 Increased By ▲ 0.35 (3.26%)
PAEL 40.40 Increased By ▲ 0.46 (1.15%)
PIAHCLA 26.44 Increased By ▲ 0.27 (1.03%)
PIBTL 17.37 Increased By ▲ 0.05 (0.29%)
PPL 232.50 Decreased By ▼ -0.28 (-0.12%)
PRL 34.98 Increased By ▲ 0.03 (0.09%)
PTC 67.25 Decreased By ▼ -0.31 (-0.46%)
SEARL 91.45 Increased By ▲ 0.52 (0.57%)
SSGC 27.02 Decreased By ▼ -0.15 (-0.55%)
TELE 8.58 Increased By ▲ 0.01 (0.12%)
THCCL 65.50 Increased By ▲ 5.37 (8.93%)
TPLP 9.18 Increased By ▲ 0.42 (4.79%)
TREET 24.66 Increased By ▲ 0.12 (0.49%)
TRG 72.41 Increased By ▲ 0.66 (0.92%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
By

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed for this article.